LIF and pancreatic neoplasm: Similarly, LIF depletion by genetic means or by neutralizing antibodies prevented engraftment in pancreatic xenograft models and synergized with gemcitabine to eradicate established pancreatic tumors in a syngeneic, KrasG12D-driven PDAC mouse model [104].